Lovejoy FH, Smith AL, Bresnan MJ, Wood JN, Victor DI, Adams PC: Clinical staging in Reye's syndrome. Am J Dis Child128:36, 1974
2.
Nelson DB, Sullivan-Bolyai JZ, Marks JS, Morens DM, Schonberger L.: Reye's syndrome: an epidemiologic assessment based on national surveillance 1977-1978 and a population based in Ohio 1973-1977. Reye's Syndrome. II. Edited by JF Crocker.New York, Grune & Stratton, 1979, p 33
3.
Partin JC, Schubert WK, Partin JS: Mitochondrial ultrastructure in Reye's syndrome (encephalopathy and fatty degeneration of the viscera). N Engl J Med285:1339, 1971
4.
Partin JS, McAdams AJ, McLaurin RL, Schubert WK: Brain ultrastructure in Reye's Syndrome: acute injury and repair. Reye's Syndrome. II. Edited by JF Crocker.New York, Grune & Stratton , 1979, p 237
Olson LC, Bourgeois CH, Keschamras N., Harikul S., Sanyakorn CK, et al: Encephalopathy and fatty degeneration of the viscera in Thai children. Am J Dis Child120:1, 1970
7.
Thaler MM: Reye's Syndrome due to a novel protein variant of ornithine transcarbamylase . Lancet1: 438, 1974
8.
Brown T., Brown H., Hug G.: Carbamylphosphate synthetase and ornithine transcarbamylase in liver of Reye's syndrome. N Engl J Med291: 797, 1974
9.
Starko K., Ray CG, Dominguez LB, Stromberg WL, Woodall DF, Reye's syndrome and salicylate use. Pediatrics66:859, 1980
10.
Halpin T.: Ohio Reye's syndrome surveillance. Reye's Syndrome III Symposium , Detroit, Michigan, November 6, 7, 1980
11.
Hayner N.: Risk factors in Reye's syndrome. Reye's Syndrome III Symposium , Detroit, Michigan, November 6, 7, 1980
12.
Crocker Jfs, Ozeri FL: The incidence and etiology of Reye's syndrome in eastern Canada. Reye's Syndrome. II. Edited by JFS Crocker.New York, Grune & Stratton, 1979
13.
Petty J.: Central nervous system damage with organo phosphates. Am J Med25:467, 1955
14.
' 14. Rozle KR, Laltoo M, Lee HS, Crocker JFS, Safe SS: Emulsifiers as enhancement factors in virus virulence. Reye's Syndrome. II. Edited by JFS Crocker.New York, Grune & Stratton, 1979, p 443
15.
Aprille JR, Austin J., Costello CE, Royal N.: Identification of the Reye's syndrome "serum factor." Pediatr Res14:628, 1980
16.
Segalman TY, Lee CP: Effects of plasma from Reye's syndrome patients on mitochondrial calcium metabolism . Reye's Syndrome III Symposium, Detroit, Michigan, November 6, 7, 1980
17.
Hurwitz E.: U.S. national Reye's Syndrome surveillance (1974-1979). Reye's Syndrome III Symposium, Detroit, Michigan, Nov. 6, 7, 1980
18.
Nelson DB, Sullivan-Bolyai JZ, Marks JS, Morens DM, Schonberger L.: Opcit, Reye's Syndrome II, p 42
Shapiro HM, Wyte SR, Laeser J.: Barbiturate augmented hypothermia for reduction of persistent intracranial hypertension. J Neurosurg40:90, 1974
21.
Marshall LF: Pentobarbital therapy in intracranial hypertension states. Reye's Syndrome III Symposium, Detroit, Michigan , November 6, 7, 1980
22.
Barker GA: The role of decompressive craniectomy in Reye's Syndrome. J Natl Reye's Syndrome Foundation1:73, 1980
23.
Samaha FJ, Blau E.: The role of peritoneal dialysis in Reye's Syndrome. Reye's Syndrome. I. Edited by JD Pollack.New York, Grune & Stratton , p 295
24.
Lansky LL, Kalarisky SM, Brackett EC: Hypothermic total body washout and intracranial pressure monitoring in stage IV of Reye's syndrome. J Pediatr90:639, 1977
25.
Delong GR, Glick TH, Shannon DC: Citrulline for Reye's syndrome. N Engl J Med290:421, 1974
26.
Bobo R., Partin JC, Partin JS, Schubert WK: Reye's syndrome in Cincinnati. Treatment with exchange transfusion . J Pediatr87:881, 1975